跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ADRENALINA BASI 1 MG/ML SOLUCIÓN INYECTABLE - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ADRENALINA BASI 1 MG/ML SOLUCIÓN INYECTABLE
Approved
STANDARD
ADRENALINA BASI 1 MG/ML SOLUCIÓN INYECTABLE
Laboratorios Basi Industria Farmaceutica S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 1, 2023
Approval ID
3795e9dfe5dd0dfe
Company
Laboratorios Basi Industria Farmaceutica S.A.
Type
Standard
Approval Details
Approval Id
3795e9dfe5dd0dfe
Drug Cima Aemps Name
ADRENALINA BASI 1 MG/ML SOLUCIÓN INYECTABLE
Register Number
89175
Holder Company Name
Laboratorios Basi Industria Farmaceutica S.A.
Marketing Company Name
Laphysan S.A.U.
Authorization Date
2023-12-01
Dosage Form
SOLUCIÓN INYECTABLE
Dose
1 mg/ml
Route Of Administration
VÍA INTRAMUSCULAR
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Laboratorios Basi Industria Farmaceutica S.A.
Active Ingredients
EPINEFRINA TARTRATO
1,82 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 1, 2023
Approval ID
3795e9dfe5dd0dfe
Type
Standard
Back to CIMA-AEMPS Approvals
